Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune landscapes in patients with gastric adenocarcinoma

被引:0
|
作者
Hong, Haidu [1 ]
Huang, Yuancheng [2 ,3 ]
Yang, Zehong [4 ]
Jiang, Xiaotao [4 ]
Liu, Hong [5 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China
[2] Southern Med Univ, Dongguan Peoples Hosp, Dept Oncol, Affiliated Hosp 10, Dongguan 523000, Guangdong, Peoples R China
[3] Southern Med Univ, Dongguan Peoples Hosp, Canc Ctr, Affiliated Hosp 10, Dongguan 523000, Guangdong, Peoples R China
[4] Guangzhou Univ Chinese Med, Clin Med Coll 1, Guangzhou 510405, Guangdong, Peoples R China
[5] Guangdong Pharmaceut Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Gonghexiheng St 1, Guangzhou 510080, Guangdong, Peoples R China
关键词
Gastric adenocarcinoma; Pyroptosis; Long non-coding RNAs; Prognostic signature; Tumor microenvironment; Immunotherapy; NONCODING RNAS; EXPRESSION;
D O I
10.1007/s12672-024-01579-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectivesThe purpose of this study was to investigate the significance of pyroptosis-related lncRNAs (PRlncRNA) in predicting prognoses and immune landscapes of patients with gastric adenocarcinoma (STAD).MethodsTranscriptomic data and clinicopathological data were obtained from The Cancer Genome Atlas database. Based on correlation analysis and univariate Cox regression, prognostic PRlncRNA were identified. Subsequently, a PRlncRNA prognostic signature (PRLPS) was generated via least absolute shrinkage and selection operator (LASSO) regression, Kaplan-Meier method, receiver operating characteristic (ROC) curves, principal component analysis, and univariate and multivariate regression. Besides, the clinicopathological characteristics, tumor microenvironment (TME) scores, the immune landscapes in different risk subgroups were explored. Moreover, based on three PRlncRNA, we constructed a competing endogenous RNA (ceRNA) network. Additionally, Gene Set Enrichment Analysis (GSEA), Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) and Gene Ontology (GO) analysis were performed for biological functional analysis based on the difference between high- and low- risk groups, which also used to screen out potential STAD drugs.Results21 PRlncRNA made up the prognostic signature, which had significant value in predicting the overall survival (OS), clinicopathological features, TME, immune checkpoint genes expression, and the response to immune checkpoint inhibitors of patients with STAD. In a addition, we constructed a ceRNA network comprising 3 PRlncRNAs and 69 mRNAs. The function of PRlncRNA was related to cancer-associated pathways. Ten small molecular drugs that might improve the prognosis of patients were screened out by connectivity maps.ConclusionsUsing PRlncRNA as a prognostic indicator for STAD, we identified predictive biomarkers and immunotherapy targets while refreshing our understanding.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Pyroptosis-related gene signature for predicting gastric cancer prognosis
    Khamis, Salem Saeed Saad
    Lu, Jianhua
    Yi, Yongdong
    Rao, Shangrui
    Sun, Weijian
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
    Tanzhu, Guilong
    Li, Na
    Li, Zhanzhan
    Zhou, Rongrong
    Shen, Liangfang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma
    Xu, Xiang
    Liang, Jia-Hua
    Li, Jian-Hui
    Xu, Qiong-Cong
    Yin, Xiao-Yu
    GASTROENTEROLOGY REPORT, 2022, 10
  • [24] Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma
    Lin, Chunxuan
    Lin, Kunpeng
    Lin, Xiaochun
    Yuan, Hai
    Zhang, Yingying
    Xie, Zhijun
    Dai, Yong
    Liu, Luhao
    Shimada, Yoshihisa
    Goto, Taichiro
    Okuda, Katsuhiro
    Liu, Taisheng
    Wei, Chenggong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (10)
  • [25] Comprehensive Analysis for Predicting Prognoses and Immune Responses of m6A-Related lncRNAs in Women with Lung Adenocarcinoma
    Wu, Sijie
    Tu, Qinxian
    Yuan, Haoyong
    Wu, Zhongshi
    Yang, Yifeng
    Chen, Chunyang
    Huang, Can
    BIOCHEMICAL GENETICS, 2023, 62 (4) : 2702 - 2720
  • [26] A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective study
    Dong, Jiaxin
    Tao, Tao
    Yu, Jiaao
    Shan, Huisi
    Liu, Ziyu
    Zheng, Guangzhao
    Li, Zhihong
    Situ, Wanyi
    Zhu, Xiao
    Li, Zesong
    CANCER REPORTS, 2024, 7 (01)
  • [27] Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis
    Wang, Ding
    Zhan, Xi
    Wu, Rui
    You, Yan
    Chen, Weixian
    Duan, Liang
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 3185 - 3196
  • [28] Identification of a potential prognostic model combining pyroptosis-related gene with immune microenvironment for pancreatic ductal adenocarcinoma
    Haoran Xie
    Jingxian Xu
    Qiuyan Zhao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17175 - 17187
  • [29] Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
    Sun, Xinti
    Huang, Xingqi
    Sun, Xiaojuan
    Chen, Si
    Zhang, Zeyang
    Yu, Yao
    Zhang, Peng
    FRONTIERS IN GENETICS, 2022, 13
  • [30] Identification of a potential prognostic model combining pyroptosis-related gene with immune microenvironment for pancreatic ductal adenocarcinoma
    Xie, Haoran
    Xu, Jingxian
    Zhao, Qiuyan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (19) : 17175 - 17187